Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2 - Wikidata - awgldk - TriplyDB

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

http://www.wikidata.org/entity/Q28331185

about

Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease A mean field model of ligand-protein interactions: implications for the structural assessment of human immunodeficiency virus type 1 protease complexes and receptor-specific binding Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy Antiviral therapy for human immunodeficiency virus infections Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys.Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.Antiretroviral drug resistance in human immunodeficiency virus type 2.Comparative studies on retroviral proteases: substrate specificity.Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors.Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes.Solvent accessibility as a predictive tool for the free energy of inhibitor binding to the HIV-1 protease.Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.

P2860

Q24530002-D33C728F-087C-41D4-AAAA-9693BD9D4AF4 Q27732012-6DB82192-B187-4BE1-867B-DDCF8FFB01C3 Q28369528-76B3342A-3650-4B2F-BE6E-72A24DF452A5 Q28378566-9018F666-CEE6-4373-86B1-52260E088F8E Q28378646-36CB572C-348F-46E3-BF82-EDC28D47F076 Q30850215-DE502346-878E-4938-A399-0B070664D585 Q33597809-4E853423-618F-49CC-BD45-62F7C2C1A414 Q33966329-33E514CE-EA2C-4DDB-928D-E71EA9ADAEC7 Q35366050-72B5B1F5-05E5-4455-9510-63DD7CEAB35D Q35636029-D80F95EB-03C5-44BC-A254-E9B3B7C0D678 Q35821454-10FB9B32-3427-4790-B787-A2117BB35C1C Q36239954-085F502B-F695-4E4F-8277-FA28B2425367 Q37059742-9E78010D-EB8E-4AEB-8C9D-91999C021BB6 Q37059887-26CD9F02-E51F-47E9-BF90-108F1098D508 Q37256366-EA9E9214-8373-40CB-B944-F0843B190625 Q37496287-EB36D07E-2028-4A72-8B4D-83F1FB33CD32 Q38613993-7CAD8D30-9570-44D1-A23B-2EECD70E2753 Q38820118-3E93382C-8E41-465D-9893-111B61F3C3BF Q40064198-AD7482A6-8B5A-4C4A-809A-51B4769CE6F2 Q41816295-AE66F8B3-C9A7-462B-87E8-A23AE24B7786 Q42842599-905FA993-AC77-4509-AB40-4D9EEA9056B1 Q42994694-03BF5EBF-A718-4369-9E86-A5F4979E9BDC

P2860

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

http://www.wikidata.org/entity/Q28331185

description

1990 nî lūn-bûn

@nan

1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@ast

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@en

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@nl

type

label

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@ast

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@en

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@nl

prefLabel

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@ast

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@en

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@nl

P1433

Q28331185-812DABBE-DCA2-4F5F-9A0E-208B20F55F61

P1476

Q28331185-1D4A1136-5640-42D1-8786-93280BB79B79

P2093

Q28331185-05DE2F3A-302A-4DEA-85EC-1195516FA66C

Q28331185-3BFDA699-BCE3-483A-9524-4BA2ACC5EB9B

Q28331185-56167C8D-EBFC-4432-98E3-F078D33A5886

Q28331185-69B1C704-BCE6-41C0-AFD6-9A9944EAD07D

Q28331185-86330FDD-4886-4DB7-9862-6501EB6D401B

Q28331185-AB7DAF2D-113B-4CF4-BD58-7B9211B533B8

Q28331185-B09F2874-DA16-4076-8A09-2B2D9B6D8699

Q28331185-B6AF927C-B3C0-4182-8562-F61922BBDD6A

Q28331185-C63A578F-E70C-4C42-98C4-41780A8B69A6

Q28331185-D8071F97-5295-4E01-B7F0-85C2595C1D53

P304

Q28331185-76DEFD7A-5771-4E28-BB77-FA26C67E6DC1

P31

Q28331185-C1009CC9-8745-4AD2-892C-EC6E102ACABC

P407

Q28331185-814EAC08-0CAA-4711-A27B-1A95BBECECAD

P433

Q28331185-64491FF6-3AAC-4CB6-BE89-9E2121C871C1

P478

Q28331185-5438A76E-6AF1-4E6C-949E-119097991CFF

P577

Q28331185-B75717AC-BFB7-4178-B8D0-EB2786498CE4

P698

Q28331185-2A1ECC1E-CD55-4C8D-BFAB-56CB62FD366F

P1433

Journal of Biological Chemistry

P1476

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2

@en

P2093

A G Tomasselli

http://www.w3.org/2001/XMLSchema#string

C Bannow

http://www.w3.org/2001/XMLSchema#string

C S Craik

http://www.w3.org/2001/XMLSchema#string

D J Staples

http://www.w3.org/2001/XMLSchema#string

D L DeCamp

http://www.w3.org/2001/XMLSchema#string

I M Reardon

http://www.w3.org/2001/XMLSchema#string

J O Hui

http://www.w3.org/2001/XMLSchema#string

R L Heinrikson

http://www.w3.org/2001/XMLSchema#string

T K Sawyer

http://www.w3.org/2001/XMLSchema#string

W J Howe

http://www.w3.org/2001/XMLSchema#string

P304

14675-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

265

http://www.w3.org/2001/XMLSchema#string

P577

1990-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2201691

http://www.w3.org/2001/XMLSchema#string